Loading institutional data...
Loading institutional data...
Insufficient data to determine institutional momentum.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
How management deployed cash over 10 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Reinvestment has been productive — operating income grew well per dollar put in. Current ROIC on all capital: 4%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
6/8 of the 9 checks — 1 couldn't be scored (see above), so the score is out of the 8 with data.
Insufficient balance-sheet detail (needs retained earnings, working capital, equity).
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Earnings are backed by cash (FCF ≥ net income) — high quality. Lower/negative accruals = higher quality (Sloan).
Comfortably covers interest; leverage rising year-over-year.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $118M buybacks = $118M returned on $949M FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Insufficient EBITDA/debt history.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Interest is easily covered by operating profit. Effective rate ~0.9% on $2.3B of debt.
Cash of $1.7B fully covers short-term debt of $695M.
Mostly short-term debt (balance-sheet current vs non-current split). A year-by-year maturity schedule wasn't disclosed for this issuer.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Educational — not a recommendation.
No trend data available for this metric.
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.34B 100.0% | $26.83B 100.0% | $22.53B 100.0% | $21.90B 100.0% | $19.38B 100.0% | $12.00B 100.0% | $6.78B 100.0% | $4.13B 100.0% | $2.47B 100.0% | $523.3M 100.0% |
| Cost of Revenue | $2.75B 63.4% | $18.06B 67.3% | $17.09B 75.8% | $18.05B 82.4% | $15.34B 79.1% | $9.16B 76.3% | $5.59B 82.4% | $3.27B 79.3% | $1.92B 77.8% | $772.8M 147.7% |
| Gross Profit | $1.59B 36.6% | $8.77B 32.7% | $5.44B 24.2% | $3.85B 17.6% | $4.04B 20.9% | $2.84B 23.7% | $1.19B 17.6% | $855.4M 20.7% | $549.2M 22.2% | -$249.5M -47.7% |
| Research & Development | $505.3M 11.6% | $3.69B 13.7% | $4.47B 19.8% | $4.77B 21.8% | $2.84B 14.7% | $1.51B 12.6% | $894.4M 13.2% | $537.5M 13.0% | $280.1M 11.3% | $91.2M 17.4% |
| Selling, General & Admin | $294.9M 6.8% | $2.03B 7.6% | $2.12B 9.4% | $2.52B 11.5% | $1.84B 9.5% | $976.1M 8.1% | $592.5M 8.7% | $461.2M 11.2% | $260.9M 10.6% | $451.3M 86.2% |
| Total Operating Expenses | $1.43B 32.9% | $10.12B 37.7% | $10.51B 46.6% | $12.21B 55.7% | $10.47B 54.0% | $5.98B 49.8% | $2.69B 39.6% | $1.58B 38.4% | $773.5M 31.3% | $645.2M 123.3% |
| Operating Income | $160.8M 3.7% | -$1.34B -5.0% | -$5.06B -22.5% | -$8.36B -38.2% | -$6.43B -33.2% | -$3.14B -26.2% | -$1.50B -22.1% | -$729.0M -17.7% | -$224.3M -9.1% | -$894.7M -171.0% |
| Interest Expense | $21.5M 0.5% | $89.2M 0.3% | $164.9M 0.7% | $250.9M 1.1% | $155.5M 0.8% | $108.5M 0.9% | $46.5M 0.7% | — | — | — |
| Other Income (Expense), net | $12.0M 0.3% | -$56.2M -0.2% | $331.2M 1.5% | $954.4M 4.4% | -$284.4M -1.5% | $140.3M 1.2% | $227.5M 3.4% | $189.9M 4.6% | $18.5M 0.8% | -$3.7M -0.7% |
| Pretax Income | — | — | — | — | — | — | — | -$78.4M -1.9% | -$174.9M -7.1% | -$908.4M -173.6% |
| Income Tax Expense | $2.5M 0.1% | -$36.5M -0.1% | $78.7M 0.3% | $104.1M 0.5% | $95.3M 0.5% | $53.4M 0.4% | $35.9M 0.5% | $26.0M 0.6% | $8.9M 0.4% | $3.1M 0.6% |
| Net Income | $170.7M 3.9% | -$1.35B -5.0% | -$4.82B -21.4% | -$7.51B -34.3% | -$6.81B -35.1% | -$3.05B -25.5% | -$1.30B -19.2% | -$565.0M -13.7% | -$183.8M -7.4% | -$911.5M -174.2% |
| Per Share | ||||||||||
| EPS (Basic) | $0.41 | $-3.23 | $-11.67 | $-18.99 | $-17.87 | $-8.71 | $-3.99 | $-2.64 | $-8.17 | $-20.42 |
| EPS (Diluted) | $0.39 | $-3.23 | $-11.67 | $-18.99 | $-17.87 | $-8.71 | $-3.99 | $-2.64 | $-8.17 | $-20.42 |
| Weighted Avg Shares (Basic) | — | — | — | — | — | — | 323.2M | 233.0M | 69.9M | 58.0M |
| Weighted Avg Shares (Diluted) | — | — | — | — | — | — | 323.2M | 233.0M | 69.9M | 58.0M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
No current price collected.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
High operating leverage: profit moved 1.3× as fast as sales — great in an upturn, painful in a downturn.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 79.3 | 82.4 | 76.3 | 79.1 | 82.4 | 75.8 | 67.3 | 63.4 |
| Gross Profit | 20.7 | 17.6 | 23.7 | 20.9 | 17.6 | 24.2 | 32.7 | 36.6 |
| R&D | 13.0 | 13.2 | 12.6 | 14.7 | 21.8 | 19.8 | 13.7 | 11.6 |
| SG&A | 11.2 | 8.7 | 8.1 | 9.5 | 11.5 | 9.4 | 7.6 | 6.8 |
| Operating Income | -17.7 | -22.1 | -26.2 | -33.2 | -38.2 | -22.5 | -5.0 | 3.7 |
| Income Tax | 0.6 | 0.5 | 0.4 | 0.5 | 0.5 | 0.3 | -0.1 | 0.1 |
| Net Income | -13.7 | -19.2 | -25.5 | -35.1 | -34.3 | -21.4 | -5.0 | 3.9 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on BILI: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.